Induction of IL-25 Expression in Human Nasal Polyp Epithelium by Influenza Virus Infection is Abated by Interferon-Alpha Pretreatment

References

• Shi JB, Fu QL, Zhang H, et al. Epidemiology of chronic rhinosinusitis: results from a cross-sectional survey in seven C hinese cities. Allergy. 2015;70(5):533–539. doi:10.1111/all.12577
   PubMed Web of Science ®Google Scholar
• Fokkens WJ, Lund VJ, Mullol J, et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl. 2012;23:1–298.
   Google Scholar
• Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(Suppl S29):1–464. doi:10.4193/Rhin20.600
   Google Scholar
• Chin D, Harvey RJ. Nasal polyposis: an inflammatory condition requiring effective anti-inflammatory treatment. Curr Opin Otolaryngol Head Neck Surg. 2013;21(1):23–30. doi:10.1097/MOO.0b013e32835bc3f9
   PubMed Web of Science ®Google Scholar
• Steelant B, Seys SF, Boeckxstaens G, Akdis CA, Ceuppens JL, Hellings PW. Restoring airway epithelial barrier dysfunction: a new therapeutic challenge in allergic airway disease. Rhinology. 2016;54(3):195–205. doi:10.4193/Rhin15.376
   PubMed Web of Science ®Google Scholar
• Angkasekwinai P, Park H, Wang YH, et al. Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med. 2007;204(7):1509–1517. doi:10.1084/jem.20061675
   PubMed Web of Science ®Google Scholar
• Shin HW, Kim DK, Park MH, et al. IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2015;135(6):1476–1485 e1477. doi:10.1016/j.jaci.2015.01.003
   PubMed Web of Science ®Google Scholar
• Fort MM, Cheung J, Yen D, et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity. 2001;15(6):985–995. doi:10.1016/s1074-7613(01)00243-6
   PubMed Web of Science ®Google Scholar
• Ballantyne SJ, Barlow JL, Jolin HE, et al. Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. J Allergy Clin Immunol. 2007;120(6):1324–1331. doi:10.1016/j.jaci.2007.07.051
   PubMed Web of Science ®Google Scholar
• Tan KS, Lim RL, Liu J, et al. Respiratory viral infections in exacerbation of chronic airway inflammatory diseases: novel mechanisms and insights from the upper airway epithelium. Front Cell Dev Biol. 2020;8:99. doi:10.3389/fcell.2020.00099
   PubMed Web of Science ®Google Scholar
• Jumat MR, Yan Y, Ravi LI, et al. Morphogenesis of respiratory syncytial virus in human primary nasal ciliated epithelial cells occurs at surface membrane microdomains that are distinct from cilia. Virology. 2015;484:395–411. doi:10.1016/j.virol.2015.05.014
   PubMed Web of Science ®Google Scholar
• Lloyd CM, Saglani S. Epithelial cytokines and pulmonary allergic inflammation. Curr Opin Immunol. 2015;34:52–58. doi:10.1016/j.coi.2015.02.001
   PubMed Web of Science ®Google Scholar
• Jackson DJ, Johnston SL. The role of viruses in acute exacerbations of asthma. J Allergy Clin Immunol. 2010;125(6):1178–1187. doi:10.1016/j.jaci.2010.04.021
   PubMed Web of Science ®Google Scholar
• Grissell TV, Powell H, Shafren DR, et al. Interleukin-10 gene expression in acute virus-induced asthma. Am J Respir Crit Care Med. 2005;172(4):433–439. doi:10.1164/rccm.200412-1621OC
   PubMed Web of Science ®Google Scholar
• Cho GS, Moon BJ, Lee BJ, et al. High rates of detection of respiratory viruses in the nasal washes and mucosae of patients with chronic rhinosinusitis. J Clin Microbiol. 2013;51(3):979–984. doi:10.1128/jcm.02806-12
   PubMed Web of Science ®Google Scholar
• Tan KS, Yan Y, Ong HH, Chow VTK, Shi L, Wang DY. Impact of respiratory virus infections in exacerbation of acute and chronic rhinosinusitis. Curr Allergy Asthma Rep. 2017;17(4):24. doi:10.1007/s11882-017-0693-2
   PubMed Web of Science ®Google Scholar
• Peng Y, Zi XX, Tian TF, et al. Whole-transcriptome sequencing reveals heightened inflammation and defective host defence responses in chronic rhinosinusitis with nasal polyps. Eur Respir J. 2019;54(5). doi:10.1183/13993003.00732-2019
   Web of Science ®Google Scholar
• Edwards MR, Walton RP, Jackson DJ, et al. The potential of anti-infectives and immunomodulators as therapies for asthma and asthma exacerbations. Allergy. 2018;73(1):50–63. doi:10.1111/all.13257
   PubMed Web of Science ®Google Scholar
• Wen W, Liu W, Zhang L, et al. Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy. J Allergy Clin Immunol. 2012;129(6):1522–1528 e1525. doi:10.1016/j.jaci.2012.01.079
   PubMed Web of Science ®Google Scholar
• Yan Y, Tan KS, Li C, et al. Human nasal epithelial cells derived from multiple individuals exhibit differential responses to H3N2 influenza virus infection in vitro. J Allergy Clin Immunol. 2016;138(1):276–281. doi:10.1016/j.jaci.2015.11.016
   PubMed Web of Science ®Google Scholar
• Tan KS, Ong HH, Yan Y, et al. In vitro model of fully differentiated human nasal epithelial cells infected with rhinovirus reveals epithelium-initiated immune responses. J Infect Dis. 2018;217(6):906–915. doi:10.1093/infdis/jix640
   PubMed Web of Science ®Google Scholar
• Wang W, Yan Y, Li CW, et al. Live human nasal epithelial cells (hNECs) on chip for in vitro testing of gaseous formaldehyde toxicity via airway delivery. Lab Chip. 2014;14(4):677–680. doi:10.1039/c3lc51208h
   PubMed Web of Science ®Google Scholar
• Hong HY, Chen FH, Sun YQ, et al. Local IL-25 contributes to Th2-biased inflammatory profiles in nasal polyps. Allergy. 2018;73(2):459–469. doi:10.1111/all.13267
   PubMed Web of Science ®Google Scholar
• Murray CS, Poletti G, Kebadze T, et al. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax. 2006;61(5):376–382. doi:10.1136/thx.2005.042523
   PubMed Web of Science ®Google Scholar
• Deng Y, Yan Y, Tan KS, et al. MicroRNA-146a induction during influenza H3N2 virus infection targets and regulates TRAF6 levels in human nasal epithelial cells (hNECs). Exp Cell Res. 2017;352(2):184–192. doi:10.1016/j.yexcr.2017.01.011
   PubMed Web of Science ®Google Scholar
• Gao L, Yu S, Chen Q, et al. A randomized controlled trial of low-dose recombinant human interferons alpha-2b nasal spray to prevent acute viral respiratory infections in military recruits. Vaccine. 2010;28(28):4445–4451. doi:10.1016/j.vaccine.2010.03.062
   PubMed Web of Science ®Google Scholar
• Kouzaki H, Matsumoto K, Kato T, Tojima I, Shimizu S, Shimizu T. Epithelial cell-derived cytokines contribute to the pathophysiology of eosinophilic chronic rhinosinusitis. J Interferon Cytokine Res. 2016;36(3):169–179. doi:10.1089/jir.2015.0058
   PubMed Web of Science ®Google Scholar
• Hong H, Liao S, Chen F, Yang Q, Wang DY. Role of IL-25, IL-33, and TSLP in triggering united airway diseases toward type 2 inflammation. Allergy. 2020;75(11):2794–2804. doi:10.1111/all.14526
   PubMed Web of Science ®Google Scholar
• Hong H, Chen F, Sun Y, et al. Nasal IL-25 predicts the response to oral corticosteroids in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2018;141(5):1890–1892. doi:10.1016/j.jaci.2017.10.050
   PubMed Web of Science ®Google Scholar
• Hamilos DL. Host-microbial interactions in patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2014;133(3):640–653.e644. doi:10.1016/j.jaci.2013.06.049
   PubMed Web of Science ®Google Scholar
• Chan RW, Chan MC, Nicholls JM, Malik Peiris JS. Use of ex vivo and in vitro cultures of the human respiratory tract to study the tropism and host responses of highly pathogenic avian influenza A (H5N1) and other influenza viruses. Virus Res. 2013;178(1):133–145. doi:10.1016/j.virusres.2013.03.003
   PubMed Web of Science ®Google Scholar
• Beale J, Jayaraman A, Jackson DJ, et al. Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation. Sci Transl Med. 2014;6(256):256ra134. doi:10.1126/scitranslmed.3009124
   PubMed Web of Science ®Google Scholar
• Jackson DJ, Makrinioti H, Rana BM, et al. IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med. 2014;190(12):1373–1382. doi:10.1164/rccm.201406-1039OC
   PubMed Web of Science ®Google Scholar
• Akdis CA, Bachert C, Cingi C, et al. Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2013;131(6):1479–1490. doi:10.1016/j.jaci.2013.02.036
   PubMed Web of Science ®Google Scholar
• Kortekaas Krohn I, Bobic S, Dooley J, et al. Programmed cell death-1 expression correlates with disease severity and IL-5 in chronic rhinosinusitis with nasal polyps. Allergy. 2017;72(6):985–993. doi:10.1111/all.13136
   PubMed Web of Science ®Google Scholar
• Bachert C, Mannent L, Naclerio RM, et al. Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial. JAMA. 2016;315(5):469–479. doi:10.1001/jama.2015.19330
   PubMed Web of Science ®Google Scholar
• Gern JE. Virus/Allergen interaction in asthma exacerbation. Ann Am Thorac Soc. 2015;12 Suppl 2(Suppl 2):S137–143. doi:10.1513/AnnalsATS.201503-153AW
   PubMedGoogle Scholar
• Bulek K, Swaidani S, Aronica M, Li X. Epithelium: the interplay between innate and Th2 immunity. Immunol Cell Biol. 2010;88(3):257–268. doi:10.1038/icb.2009.113
   PubMed Web of Science ®Google Scholar
• Valizadeh A, Khosravi A, Zadeh LJ, Parizad EG. Role of IL-25 in immunity. J Clin Diagn Res. 2015;9(4):OE01–04. doi:10.7860/JCDR/2015/12235.5814
   PubMedGoogle Scholar
• Laza-Stanca V, Message SD, Edwards MR, et al. The role of IL-15 deficiency in the pathogenesis of virus-induced asthma exacerbations. PLoS Pathog. 2011;7(7):e1002114. doi:10.1371/journal.ppat.1002114
   PubMed Web of Science ®Google Scholar
• Contoli M, Message SD, Laza-Stanca V, et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med. 2006;12(9):1023–1026. doi:10.1038/nm1462
   PubMed Web of Science ®Google Scholar
• Wark PA, Johnston SL, Bucchieri F, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med. 2005;201(6):937–947. doi:10.1084/jem.20041901
   PubMed Web of Science ®Google Scholar
• Lam M, Hull L, Imrie A, et al. Interleukin-25 and interleukin-33 as mediators of eosinophilic inflammation in chronic rhinosinusitis. Am J Rhinol Allergy. 2015;29(3):175–181. doi:10.2500/ajra.2015.29.4176
   PubMed Web of Science ®Google Scholar